Therapeutic Role of Tangshenkang Granule(糖肾康颗粒) in Rat Model with Diabetic Nephropathy

Objective: To evaluate the renal protective effect of Tangshenkang Granule(糖肾康颗粒) in a rat model of diabetic nephropathy(DN).Methods: Forty male Sprague-Dawley rats were randomly divided into control,DN,Tangshenkang and benazepril groups.DN model was established in the rats of DN,Tangshenkang and benazepril groups.Tangshenkang Granule solution and benazepril hydrochloride solution were intragastrically administered daily to the rats in the Tangshenkang and benazepril groups for 8 weeks,respectively.Urinary albumin and creatinine were detected.The albumin/creatinine(ACR) was calculated in addition to 24 h urinary protein(24-h UPr),serum creatinine(Scr),blood urea nitrogen(BUN),total cholesterol(TC),triglyceride(TG),low-density lipoprotein(LDL),high-density lipoprotein(HDL),and creatinine clearance rate(Ccr).Right kidneys were harvested for pathological observation using periodic acid-silver methenamine-Masson staining.The average glomerular diameter(DG),average glomerular(AG) and mesangial areas(AM) were measured.The thickness of glomerular basement membrane(TGBM) was detected using transmission electron microscope.Results: Compared with rats in the control group,rats in the DN group showed significantly decreased body weight,increased hypertrophy index,24-h urinary volume,24-h UPr,ACR,Scr,BUN,Ccr,blood lipids as well as renal pathological indices including DG,AG,AM,AM/AG and TGBM(P0.05).Compared with the DN group,the weights of rats in the Tangshenkang and benazepril groups were significantly increased,and the renal hypertrophy indices were significantly decreased(P 0.05).The 24-h urinary volumes,ACR,24-h UPr,Scr,BUN,Ccr,LDL,DG,AG,AM and TGBM were obviously decreased(P 0.05).Compared with the benazepril group,the Tangshenkang group showed significantly decreased levels of ACR,24-h UPr,AG and AM(P 0.05).Conclusion: Tangshenkang Granule decreased the urinary protein,attenuated the high glomerular filtration rate and improved lipid metabolism in DN rats,and prevented further injury induced by diabetic nephropathy.     

Clinical Observation on Treatment of Diabetic Nephropathy by Tangweikang (糖微康) Capsule

Ｄｉａｂｅｔｉｃｎｅｐｈｒｏｐａｔｈｙ (ＤＮ)ｉｓｏｎｅｏｆｔｈｅｃｏｍｍｏｎｃｏｍｐｌｉｃａｔｉｏｎｓｉｎｍｉｃｒｏｖｅｓｓｅｌｓｏｆｄｉａ ｂｅｔｅｓｍｅｌｌｉｔｕｓ (ＤＭ ) .Ａｔｐｒｅｓｅｎｔｔｈｅｒｅｉｓｎｏｉｄｅａｌｔｈｅｒａｐｙｔｏｃｕｒｅｉｔ.     

Clinical Observastion on 30 Cases of Chronic Renal Failure Trested with Shentekang Capsule(肾特康胶囊) and Peritoneal Dialysis

ＣｌｉｎｉｃａｌＯｂｓｅｒｖｓｔｉｏｎｏｎ３０ＣａｓｅｓｏｆＣｈｒｏｎｉｃＲｅｎａｌＦａｉｌｕｒｅＴｒｅｓｔｅｄｗｉｔｈＳｈｅｎｔｅｋａｎｇＣａｐｓｕｌｅａｎｄＰｅｒｉｔｏｎｅａｌＤｉａｌｙｓｉｓ￥ＹＥＲｅｎ－ｇａｏ；ＲＥＮＧｕｏ－ｈｕｉ；ＬＩＨｕｉ...     

Anti-inflammatory Effects of Xuezhikang Capsule (血脂康胶囊)

IthasbeenprovedthatXuezhikangCapsule(XZK,血脂康胶囊),aChinesered yeastriceextract,con tainsmultiplenaturalstatins(8monacolins)andothercomponents,whichcouldsignificantlyreducethetotalcholesterol(TC)andLDL cholesterolconcentrationsinblood.Itsbenefitsoncoro aryheartdiseaseshavebeenstudiedintherecentlyconductedChineseCoronarysecondarypre ventionstudy(CCSPS).TheresultsshowedthatXZKcannotonlysignificantlydecreasetheinci denceofnonfatalmyocardialinfarctionanddeathsfromCHD,butalsosignificantl…     

糖肾康胶囊简介

1处方来源及背景资料 糖肾康胶囊处方来源于天津市第一医院的医院制剂，已临床医用十几年，证明是有效的方剂。自1992年，天津市科委多次资助该项目的研究。     

Effects of Corocalm (Shuguan Capsule, 疏冠胶囊) on acute myocardial ischemia in anesthetized dogs

Objective:To investigate the effects of Corocalm (Shuguan Capsule,疏冠胶囊) on acute myocardial ischemia in anesthetized dogs and its possible therapeutic mechanism.Methods:The acute ischemia model was established by ligating the left anterior descending (LAD) artery.Twenty- five dogs were randomly divided into 5 groups (5 clogs in each group):the control group (treated with normal saline 3 mL/kg),the refined Guanxin Capsule group (精制冠心胶囊,GXC 200 mg/kg),high and low dose Corocalm groups (48.5 mg/kg for low dose group and 194.0 mg/kg for high dose group) and the Diltiazem group (5 mg/kg).The animals were treated via a single duodenal administration after the model was established.The experiments used epicardial electrocardiogram (EECG) to measure the scope and degree of myocardial ischemia.Simultaneously,the coronary blood flow (CBF) and serum activity levels of creatine phosphokinase (CK) and lactate dehydrogenase (LDH) were measured by electromagnetic flow meter and automatic biochemical analyzer respectively.The plasma endothelin (ET) content was quantified by radioimmunoassay.Results:Corocalm (48.5 mg/kg and 194.0 mg/kg) significantly decreased the degree and scope of myocardial ischemia,reduced the infarct area,markedly increased the CBF,and inhibited the increase of CK and LDH activities and ET levels induced by myocardial ischemia/infarction.Conclusion:Corocalm could improve the state of acute myocardial ischemia and infarction in dogs.The mechanism of action might be correlated to increasing CBF, inhibiting CK and LDH activities and preventing ET release.     

Effect of Weikang Capsule(胃康胶囊)on Aspirin-Related Gastric and Small Intestinal Mucosal Injury

Objective:To investigate the effects of Weikang Capsule(胃康胶囊,WKC)on aspirin-related gastric and small intestinal mucosal injury by magnetically controlled capsu...     

Experimental Study on Effects of Mailuotong Granule(脉络通冲剂) on Anti-thromboangiitis Obliterans

ＥｘｐｅｒｉｍｅｎｔａｌＳｔｕｄｙｏｎＥｆｆｅｃｔｓｏｆＭａｉｌｕｏｔｏｎｇＧｒａｎｕｌｅｏｎＡｎｔｉ－ｔｈｒｏｍｂｏａｎｇｉｉｔｉｓＯｂｌｉｔｅｒａｎｓ￥ＷＡＮＧＪｕｎ；ＷＡＮＧＹｕ－ｓｈｅｎｇ；ＦＵＭａｎ－ｈｕａ；ｅｔａｌ（ＨｅｎａｎＩｎｓｔｉｔ...     

Effects of Tongguan Capsule(通冠胶囊)on Post-myocardial Infarction Ventricular Remodeling and Cardiac Function in Rats

<正>Objective:To observe the effects of Tongguan Capsule(通冠胶囊,TGC) on post-myocardial infarction ventricular remodeling and heart function in rats.Methods:A rat model of acute myocardial infarction (AMI) was established by coronary ligation.Experimental rats were randomized to 4 groups including three model groups(Group A:captopril 5 mg/kg·day,n=7;Group B:TGC 10 g/kg·day,n=7;and Group C:placebo, n=8),and a sham-control group(Group D:blank control,n=6).Animals were treated for 4 weeks.The cardiac function of rats was assessed at the end of the experiment based on left ventricular ejection fraction(LVEF) and left ventricular short axis fractional shortening(LVFS) detected by colored echocardiography;meanwhile, the condition of ventricular remodeling was observed through the levels of left ventricular mass(LVM),plasma aldosterone(ALD),myocardial angiotensinⅡ(AngⅡ) and myocardial collagen measurements.Results:At the end of the experiment,LVEF and LVFS in Group A and B were improved significantly,while those in Group C were unchanged,the LVEF in Group A,B,C,and D was 0.57±0.46,0.61±0.08,0.36±0.55 and 0.76±0.02,respectively;and their LVFS was 0.31±0.52,0.34±0.04,0.23±0.57 and 0.45±0.03,respectively.The difference was statistically significant when comparing the two indexes in Group A and B with those in Group C and D(P0.05).LVM,levels of plasma ALD and myocardial AngⅡwere lower in Group A and B than in Group C,but a comparison between Group A and B showed an insignificant difference in lowering LVM and ALD,while the lowering of AngⅡwas more significant in Group B than in Group A(754.7±18.7 pg/mL vs 952.6±17.6 pg/ mL,P0.05).Morphological examination showed that in Group A and B the swollen myocardial cells had shrunk, with regularly arranged myocardial fibers and decreased collagen proliferation,but the improvements in Group B were more significant.Conclusion:TGC could markedly improve the post-infarction ventricular remodeling and cardiac function in rats,showing that the efficacy was better than or equal to that of captopril.     

Effects of Zhizi Chuanxiong Capsule (栀子川芎胶囊) on Abnormal Methylation in Rabbits with Atherosclerosis

Objective: To investigate the effects of Zhizi Chuanxiong Capsule(ZCC, 栀子川芎胶囊) on abnormal DNA methylation in a rabbit model of atherosclerosis(AS). Methods: After 1 week of adaptive feeding, 48 New Zealand white rabbits were randomly divided into 4 groups: a control group(n=12) fed with normal diet for 22 weeks; a model group(n=12) fed with high fat diet for 14 weeks followed by 8 weeks of normal diet feeding; a low-dose ZCC group(n=12) fed with high fat diet and low-dose ZCC for 14 weeks, followed by 8 weeks of normal diet and low-dose drug; a high-dose ZCC group(n=12) fed with high fat diet and high-dose drug for 14 weeks, followed by 8 weeks of normal diet and high-dose drug. After 22 weeks of feeding, blood samples were taken from the rabbit ear vein, and the genomic DNA was extracted for methylation immunoprecipitation sequencing(Medip-seq). The aorta tissues were collected for hematoxylin-eosin(HE) staining. Results: Eight rabbits died during the feeding process. HE staining showed that the size of the lipid deposition on vessel wall and atherosclerotic plaque formation were reduced in both low-and high-dose group. The Medip-seq results showed that there were 146 abnormally methylated genes(including both hypermethylated gene and hypomethylated genes) in the model group, compared with the control group. Gene Ontology(GO) and Pathway analysis showed that these abnormally methylated genes were found to be involved in multiple AS-related functions and pathways, such as protein kinase C activity, cholesterol transport, mitogen-activated protein kinase(MAPK) signaling pathway, peroxisome proliferater-activated receptor signaling pathway, vascular smooth muscle contraction, inflammation and so on. The abnormal methylated genes in AS model group were altered in both low-and high-dose groups: low-dose ZCC could change 72 of the 146 abnormally methylated genes, highdose ZCC could change 71. Through GO and Pathway analysis, these altered methylated genes were involved in protein kinase C activity, inflammatory pathway, MAPK signaling pathway, vascular endothelial growth factor signaling pathway, etc. Conclusion: ZCC could treat AS through regulating the abnormal hypermethylated and hypomethylated genes in AS rabbit model.     

急性脑梗塞病人血浆血栓素B_2,6-酮-前列腺素F_(1a)的动态观察

本文对53例动脉硬化性脑梗塞患者发病后10天内血浆血栓素 B_2(TXB_2)、6-酮-前列腺素 F_(1a)(6-Keto-PGF_(1a))的变化进行观察,以45例健康人及13例脑出血患者作为对照。结果显示脑梗塞组 TXB_2持续升高(>900 pmol/L),而6-Keto-PGF_(1a)持续降低(<300 pmol/L),脑出血组 TXB_2亦升高。     

糖肾康胶囊对早期糖尿病肾病患者血清内皮素影响的临床观察

[目的] 观察糖肾康胶囊对早期糖尿病肾病（DN）患者血清内皮素的影响,从而探讨其作用机制。[方法] 选取糖尿病肾病微量白蛋白尿期患者60例,随机分为治疗组和对照组各30例,两组均应用基础治疗,治疗组同时采用糖肾康胶囊,3粒/次,3次/日,圆个月为员个疗程,3个疗程后观察治疗前后血清内皮素-1（EF-1）及尿微量白蛋白排泄率（UAER）、糖化血红蛋白（Hbalc）、胆固醇（TC）、甘油三酯（TG）、低密度脂蛋白（LDL）、高密度脂蛋白（HDL）的变化,并进行统计学分析。[结果] 治疗组治疗后血清ET-1及尿微量白蛋白、TG、TG、LDL、HDL的变化与对照组相比差异有统计学意义。[结论] 糖肾康胶囊能够降低血ET-1的含量,减少尿微量白蛋白,可能是通过改善高凝状态、减少缺血、缺氧状态的作用,而保护内皮细胞、减轻肾小球的硬化。     

Ⅱ型糖尿病微血管病变患者血清TXB_2 6K-PGF_(1α) LPO含量变化及意义

采用RIA、TBA荧光法分别测定了64例Ⅱ型糖尿病患者的血清TXB2、6K—PGF_(1α)及LPO含量,并与30名健康人比较。结果证实,糖尿病组血清TXB_2、LPO含量升高,6K-PGF_(1α)含量降低,TXB_2/6K-PGF_(1α)比值升高。以上变化以微血管病变组最为显著,其血清LPO含量与TXB_2呈正相关;与6K-PGF_(1α)呈负相关。TXB_2/6K-PGF_(1α)比值升高与糖脂代谢异常、血清LPO升高相一致。     

前列腺素E1联合百令胶囊治疗糖尿病肾病临床观察

目的 观察静脉输注前列腺素E1(PGE1)联合口服百令胶囊对糖尿病肾病患者肾功能及尿白蛋白的影响.方法 糖尿病肾病患者155例,随机分为对照组、PGE1组、百令胶囊组及治疗组,治疗组应用PGE1联合百令胶囊治疗,PGE1组应用PGE1治疗,百令胶囊组应用百令胶囊治疗,对照组应用复方丹参注射液治疗.结果 治疗后治疗组、PGE1组、百令胶囊组尿白蛋白排泄量和血肌酐含量均明显下降,与治疗前比较差异有统计学意义(P＜0.05).治疗后PGE1组、百令胶囊组、治疗组分别与对照组尿白蛋白排泄量和血肌酐含量比较,差异有统计学意义(P＜0.05),治疗组与PGE1组、百令胶囊组作治疗后比较,差异有统计学意义(P＜0.05).治疗后随访3个月,尿白蛋白和血肌酐含量无明显变化.结论 前列腺素E1、百令胶囊均能减少糖尿病肾病患者尿白蛋白排泄量和血肌酐水平,改善肾功能,两药联用疗效优于两药单用.     

糖肾康颗粒对糖尿病肾病气阴两虚、瘀血阻络证患者血清胱抑素C及尿纤维连接蛋白的干预作用

目的观察Ⅲ~Ⅳ期糖尿病肾病(diabetic nephropathy,DN)气阴两虚、瘀血阻络证患者血清胱抑素C(cystatin C,CysC)、尿纤维连接蛋白(urinary fibronectin,UFn)水平及糖肾康颗粒的干预作用。方法将60例Ⅲ~Ⅳ期糖尿病肾病气阴两虚、瘀血阻络证患者随机分为治疗组和对照组,各30例,并选取20名健康体检者作为正常组。治疗组与对照组均给予常规降糖、降压治疗,治疗组加用糖肾康颗粒,疗程2个月。治疗前后分别检测治疗组与对照组尿白蛋白/尿肌酐比值(microalbuminuria/urine creatinine,MAU/UCr)、肾小球滤过率估算值(estimated glomerular filtration rate,eGFR)以及CysC、UFn水平,并与正常组比较。结果治疗组中医证候疗效显著优于对照组(P0.01);在降低MAU/UCr比值和CysC、UFn水平,以及升高eGFR水平方面,治疗组显著优于对照组(P0.01)。结论糖肾康颗粒可降低Ⅲ~Ⅳ期DN气阴两虚、瘀血阻络证患者血清CysC、UFn水平,并可减少DN患者尿蛋白排泄,维持肾小球滤过率,在一定程度上具有保护肾功能、延缓疾病进展的作用。     

糖肾康颗粒对糖尿病肾病患者尿蛋白的影响

目的:观察糖肾康颗粒对糖尿病肾病患者PCX、Nephrin、Podocin表达的干预作用。方法:72例糖尿病肾病患者随机分为观察组和对照组各36例,最终完成69例,观察组35例,对照组34例。观察组与对照组均给予基础治疗,观察组加服糖肾康颗粒口服,每日3次,每次10g。两组疗程均为8周。观察两组的临床疗效、中医证候积分变化、治疗前后UACR、24hUPr及尿中PCX、Nephrin、Podocin蛋白的变化情况。结果:观察组临床疗效和中医证候疗效均优于对照组(P<0.05)。两组治疗后中医证候积分、UACR、24hUPr较治疗前均显著下降(P<0.01),但观察组均显著优于对照组(P<0.01)。两组治疗前尿PCX、Nephrin、Podocin水平均高于正常组(P<0.01);治疗后两组尿PCX、Nephrin、Podocin水平均较治疗前降低(P<0.05或P<0.01),但观察组均显著优于对照组(P<0.05)。结论:糖肾康颗粒可有效改善糖尿病肾病患者的临床症状,减少尿蛋白,其作用机制可能与保护足细胞而降低尿中PCX、Nephrin、Podocin蛋白的表达有关。     

糖肾康颗粒对糖尿病肾病患者血清同型半胱氨酸及脂质代谢紊乱的影响

目的 观察糖肾康颗粒对糖尿病肾病（diabetic nephropathy,DN）气阴两虚血瘀证患者血清同型半胱氨酸（homocysteine,Hcy）及脂质代谢紊乱的干预作用。〖JP2〗方法 将60例DN气阴两虚血瘀证患者随机分为试验组和对照组各30例,在降压治疗基础上,试验组给予糖肾康颗粒冲服,对照组给予缬沙坦胶囊口服。治疗16周后,检测尿微量白蛋白/尿肌酐比值（urine albumin-to-creatinine ratio,UACR）、24 h尿蛋白（24-hour proteinuria,24hUpro）、血肌酐（serum creatinine, SCr）、估算肾小球滤过率（estimated glomerular filtration rate,eGFR）、血清Hcy、总胆固醇（total cholesterol,TC）、三酰甘油（triglyceride, TG）、低密度脂蛋白胆固醇（low density lipoprotein-cholesterol, LDL-C）、高密度脂蛋白胆固醇（high density lipoprotein-cholesterol, HDL-C）、载脂蛋白-A1（apolipoprotein A1, ApoA1）、载脂蛋白-B（apolipoprotein B, ApoB）。结果 试验组疾病疗效显著优于对照组（P＜0.05）。两组患者治疗后UACR、24hUpro、SCr均较治疗前显著降低（P＜0.05）,eGFR较治疗前显著升高（P＜0.05）;且试验组治疗后UACR和24hUpro降低值显著大于对照组（P＜0.05）。试验组血清Hcy、TC、LDL-C、ApoB与治疗前比较均显著降低（P＜0.05）,而对照组治疗后血清Hcy、TC、LDL-C、ApoB均无明显变化（P＞0.05）,试验组治疗后Hcy、LDL-C、ApoB降低值显著大于对照组（P＜0.05）。结论 糖肾康颗粒降低DN气阴两虚血瘀证患者蛋白尿、改善肾功能的作用机制与改善高半胱氨酸血症和脂质代谢紊乱有关。     

糖尿病肾病不同阶段血浆血栓素、前列环素水平的研究

放免法测定92例糖尿病人和30例正常人的血浆血栓素B2（TXB2）和6—酮—前列环素F1α（6－keto－PGF1α）浓度．结果显示，TXB2随DN加重逐渐升高（P＜0．05或更低），DN越重，TXB2升高越明显；TXB2／6－keto－PGF1α比值变化与TXB2水平一致；尿白蛋白排泄率正常组和早期DN组病人尿白蛋白排泄率与TXB2直线正相关（r＝0．24，P＜0．05）．提示血栓素升高在DN的发病机制和进程中有作用。     

三黄益肾胶囊治疗早期糖尿病肾病临床观察

目的：观察三黄益肾胶囊与贝那普利治疗早期糖尿病的临床疗效及作用机理。方法：治疗组40例,用中药三黄益肾胶囊（本院制剂）与贝那普利治疗;对照组40例,用贝那普利治疗。3个月为1个疗程,疗程结束后,比较两组治疗前后有关指标。结果与结论：治疗后两组的空腹血糖、餐后2h血糖、胆固醇、甘油三酯、血压、24h尿微量白蛋白均明显降低,具有统计学差异（P〈0.01）;其中治疗组24h尿微量白蛋白较对照组降低更为明显,具有统计学差异（P〈0.05）。